Video Lecture APS Booth Presentation: Cost-effective Utilization of Urine Drug Testing for Chronic Pain Management Patients

The costs associated with traditional urine drug testing models can be excessive due to inappropriate testing, such as reflex confirmation testing for all positive screen results, which is not clinically useful. This presentation will focus on cost-effective strategies that eliminate unnecessary testing and inappropriate interpretations for pain management patients.

Originally presented May 17, 2012 in Honolulu, Hawaii.


Gordon Nelson, C(ASCP), NRCC-TC Gordon Nelson, C(ASCP), NRCC-TC
Chemistry Division Manager, ARUP Laboratories
Technical Vice President, ARUP Laboratories

Mr. Nelson is a technical vice president and division manager of the Chemistry Division at ARUP. The Chemistry Division includes Analytic Biochemistry, Clinical Drug Abuse Testing, Mass Spectrometry 1, Mass Spectrometry 2, Toxicology, Trace Elements and Calculi, Automated Core, Automated Endocrinology, Electrophoresis Manual Endocrinology, Manual Endocrinology 1, Manual Endocrinology 2, and Special Chemistry laboratories. Mr. Nelson has more than 20 years of laboratory experience. He is certified in chemistry by the American Society for Clinical Pathology (ASCP) and as a toxicological chemist by the National Registry of Certified Chemists. He is an inspector for the National Laboratory Certification Program conducted by the Division of Health and Human Services. Mr. Nelson received his BS degree from the University of Utah.

Sponsored by:

ARUP Laboratories